198
313
1,596
530,481
ÇöÀçÁ¢¼ÓÀÚ
: 7 (ȸ¿ø 0)
Àüü±×·ì
¾Ï¿¹¹æ¼ÒÀç°³¹ß¿¬±¸¼¾ÅÍ
±è¼ºÈÆ ±³¼ö´Ô
Àüü°Ô½Ã¹°
¿ø±Û¸¸
ÄÚ¸àÆ®¸¸
ȸ¿ø¾ÆÀ̵ð :
±×·ì
°Ô½ÃÆÇ
Á¦¸ñ
À̸§
ÀϽÃ
¾Ï¿¹¹æ¼ÒÀ硦
¹ßÇ¥³í¹®
Single Oral Dose Pharmacokinetics of Dec¡¦
ÃÖ°í°ü¸®ÀÚ
08-20
¾Ï¿¹¹æ¼ÒÀ硦
¹ßÇ¥³í¹®
Activation of c-Jun N-Terminal Kinase Me¡¦
ÃÖ°í°ü¸®ÀÚ
08-20
¾Ï¿¹¹æ¼ÒÀ硦
¹ßÇ¥³í¹®
Matrix detachment and proteasomal inhibi¡¦
ÃÖ°í°ü¸®ÀÚ
08-20
¾Ï¿¹¹æ¼ÒÀ硦
¼¾ÅÍÈ°µ¿ ¡¦
2013³â 6¿ù ¼¼¹Ì³ª
ÃÖ°í°ü¸®ÀÚ
08-20
¾Ï¿¹¹æ¼ÒÀ硦
¹ßÇ¥³í¹®
Expression patterns of MDA-9/syntenin du¡¦
ÃÖ°í°ü¸®ÀÚ
08-20
¾Ï¿¹¹æ¼ÒÀ硦
¼¾ÅÍÈ°µ¿ ¡¦
2013³â 5¿ù ¼¼¹Ì³ª II
ÃÖ°í°ü¸®ÀÚ
08-20
¾Ï¿¹¹æ¼ÒÀ硦
¹ßÇ¥³í¹®
Effects of topical application of Astrag¡¦
ÃÖ°í°ü¸®ÀÚ
08-20
¾Ï¿¹¹æ¼ÒÀ硦
¼¾ÅÍÈ°µ¿ ¡¦
2013³â 5¿ù ¼¼¹Ì³ª
ÃÖ°í°ü¸®ÀÚ
08-20
¾Ï¿¹¹æ¼ÒÀ硦
¹ßÇ¥³í¹®
Embelin inhibits growth and induces apop¡¦
ÃÖ°í°ü¸®ÀÚ
08-20
¾Ï¿¹¹æ¼ÒÀ硦
ÇмúÈ°µ¿
2013³â 7¿ù CPMDRC ¼¼¹Ì³ª
ÃÖ°í°ü¸®ÀÚ
08-20
¾Ï¿¹¹æ¼ÒÀ硦
ÇмúÈ°µ¿
2013³â 6¿ù CPMDRC ¼¼¹Ì³ª
ÃÖ°í°ü¸®ÀÚ
08-20
¾Ï¿¹¹æ¼ÒÀ硦
¹ßÇ¥³í¹®
Chrysanthemum indicum L. Extract Induces¡¦
ÃÖ°í°ü¸®ÀÚ
08-20
¾Ï¿¹¹æ¼ÒÀ硦
Çмú¹ßÇ¥
1,2,3,4,6-penta-O-galloyl-¥â-D-glucopyra¡¦
ÃÖ°í°ü¸®ÀÚ
07-29
¾Ï¿¹¹æ¼ÒÀ硦
¼½ÄÀÚ·á½Ç
2013 ÇÑÀÇ´ë MRC »ç»çÇ¥±â È®ÀκÎŹµå¸³´Ï¡¦
ÃÖ°í°ü¸®ÀÚ
07-03
¾Ï¿¹¹æ¼ÒÀ硦
ÇмúÈ°µ¿
2013³â 5¿ù CPMDRC ¼¼¹Ì³ª II
ÃÖ°í°ü¸®ÀÚ
06-12
óÀ½
1
2
3
4
5
6
7
8
9
10
´ÙÀ½
¸Ç³¡